vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and JFrog Ltd (FROG). Click either name above to swap in a different company.
JFrog Ltd is the larger business by last-quarter revenue ($145.3M vs $85.1M, roughly 1.7× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -10.5%, a 33.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 25.2%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 20.4%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
FDMT vs FROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $145.3M |
| Net Profit | $19.4M | $-15.2M |
| Gross Margin | — | 77.9% |
| Operating Margin | 17.3% | -14.7% |
| Net Margin | 22.8% | -10.5% |
| Revenue YoY | 8508900.0% | 25.2% |
| Net Profit YoY | 139.1% | 34.4% |
| EPS (diluted) | $0.43 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $145.3M | ||
| Q3 25 | $90.0K | $136.9M | ||
| Q2 25 | $15.0K | $127.2M | ||
| Q1 25 | $14.0K | $122.4M | ||
| Q4 24 | $1.0K | $116.1M | ||
| Q3 24 | $3.0K | $109.1M | ||
| Q2 24 | $5.0K | $103.0M | ||
| Q1 24 | $28.0K | $100.3M |
| Q4 25 | $19.4M | $-15.2M | ||
| Q3 25 | $-56.9M | $-16.4M | ||
| Q2 25 | $-54.7M | $-21.7M | ||
| Q1 25 | $-48.0M | $-18.5M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $-43.8M | $-22.9M | ||
| Q2 24 | $-35.0M | $-14.3M | ||
| Q1 24 | $-32.4M | $-8.8M |
| Q4 25 | — | 77.9% | ||
| Q3 25 | — | 77.4% | ||
| Q2 25 | — | 76.3% | ||
| Q1 25 | — | 75.3% | ||
| Q4 24 | — | 75.4% | ||
| Q3 24 | — | 75.0% | ||
| Q2 24 | — | 78.8% | ||
| Q1 24 | — | 79.5% |
| Q4 25 | 17.3% | -14.7% | ||
| Q3 25 | -67983.3% | -15.8% | ||
| Q2 25 | -396373.3% | -20.4% | ||
| Q1 25 | -383007.1% | -18.8% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | -1704400.0% | -27.4% | ||
| Q2 24 | -849120.0% | -18.6% | ||
| Q1 24 | -136200.0% | -16.6% |
| Q4 25 | 22.8% | -10.5% | ||
| Q3 25 | -63195.6% | -12.0% | ||
| Q2 25 | -364386.7% | -17.0% | ||
| Q1 25 | -342657.1% | -15.1% | ||
| Q4 24 | — | -20.0% | ||
| Q3 24 | -1461433.3% | -21.0% | ||
| Q2 24 | -699060.0% | -13.9% | ||
| Q1 24 | -115717.9% | -8.8% |
| Q4 25 | $0.43 | $-0.13 | ||
| Q3 25 | $-1.01 | $-0.14 | ||
| Q2 25 | $-0.98 | $-0.19 | ||
| Q1 25 | $-0.86 | $-0.16 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | $-0.79 | $-0.21 | ||
| Q2 24 | $-0.63 | $-0.13 | ||
| Q1 24 | $-0.66 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $704.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $887.4M |
| Total Assets | $566.7M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $704.4M | ||
| Q3 25 | $305.1M | $651.1M | ||
| Q2 25 | $293.2M | $611.7M | ||
| Q1 25 | $321.4M | $563.5M | ||
| Q4 24 | $424.9M | $522.0M | ||
| Q3 24 | $501.9M | $467.8M | ||
| Q2 24 | $541.9M | $591.3M | ||
| Q1 24 | $525.9M | $579.6M |
| Q4 25 | $505.7M | $887.4M | ||
| Q3 25 | $369.0M | $859.4M | ||
| Q2 25 | $420.9M | $826.5M | ||
| Q1 25 | $469.7M | $800.0M | ||
| Q4 24 | $510.6M | $773.5M | ||
| Q3 24 | $552.9M | $756.2M | ||
| Q2 24 | $588.3M | $721.4M | ||
| Q1 24 | $600.6M | $707.8M |
| Q4 25 | $566.7M | $1.3B | ||
| Q3 25 | $424.0M | $1.3B | ||
| Q2 25 | $473.6M | $1.2B | ||
| Q1 25 | $515.7M | $1.2B | ||
| Q4 24 | $560.4M | $1.1B | ||
| Q3 24 | $604.0M | $1.1B | ||
| Q2 24 | $620.1M | $1.0B | ||
| Q1 24 | $629.9M | $997.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $50.7M |
| Free Cash FlowOCF − Capex | $28.5M | $49.9M |
| FCF MarginFCF / Revenue | 33.5% | 34.3% |
| Capex IntensityCapex / Revenue | 0.1% | 0.6% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $142.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $50.7M | ||
| Q3 25 | $-46.5M | $30.2M | ||
| Q2 25 | $-43.4M | $36.1M | ||
| Q1 25 | $-47.8M | $28.8M | ||
| Q4 24 | $-134.6M | $49.1M | ||
| Q3 24 | $-29.4M | $27.6M | ||
| Q2 24 | $-30.2M | $16.7M | ||
| Q1 24 | $-29.1M | $17.5M |
| Q4 25 | $28.5M | $49.9M | ||
| Q3 25 | $-46.6M | $28.8M | ||
| Q2 25 | $-43.4M | $35.5M | ||
| Q1 25 | $-48.4M | $28.1M | ||
| Q4 24 | $-138.4M | $48.5M | ||
| Q3 24 | $-31.2M | $26.7M | ||
| Q2 24 | $-30.6M | $16.0M | ||
| Q1 24 | $-29.8M | $16.6M |
| Q4 25 | 33.5% | 34.3% | ||
| Q3 25 | -51765.6% | 21.0% | ||
| Q2 25 | -289620.0% | 27.9% | ||
| Q1 25 | -345635.7% | 23.0% | ||
| Q4 24 | -13837100.0% | 41.8% | ||
| Q3 24 | -1038966.7% | 24.5% | ||
| Q2 24 | -611840.0% | 15.5% | ||
| Q1 24 | -106421.4% | 16.6% |
| Q4 25 | 0.1% | 0.6% | ||
| Q3 25 | 101.1% | 1.0% | ||
| Q2 25 | 440.0% | 0.5% | ||
| Q1 25 | 4507.1% | 0.5% | ||
| Q4 24 | 378600.0% | 0.5% | ||
| Q3 24 | 59266.7% | 0.9% | ||
| Q2 24 | 6980.0% | 0.7% | ||
| Q1 24 | 2535.7% | 0.8% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
